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osting by EAbstract In 1939, Ota described the ﬁrst case of a benign dermal melanocytosis known as nevus of
Ota. This condition involves the skin and mucosa innervated by the ophthalmic, maxillary and,
rarely, the mandibular division of the trigeminal nerve. It is frequent in people of Japanese descent
but is also seen in individuals of Chinese, Indian, African and European descent. Nevus of Ota is
non-hereditary pigmentation disorder, which is more frequent in females than males. Unilateral pre-
sentation is typically seen, but bilateral involvement is described in 5–10% of patients. We report a
10-year-old Saudi girl with bilateral nevus of Ota associated with Turner syndrome. This is the ﬁrst
report of such an association.
ª 2010 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Case report
A 10-year-old Saudi girl with a known case of Turner syn-
drome [chromosomal analysis, 46, X, del (X) (p22)] with
growth hormone deﬁciency presented to the dermatology clinic
with an asymptomatic blue-gray lesion on the upper part of the
face that had been present since the age of 6 months. The le-
sions gradually progressed with age and extended to the fore-epartment of Dermatology,
bia. Tel.: +966 1 4691427/26;
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lsevierhead, temple and bilateral periorbital areas. They have been
static for 5 years. There was a history of lesion darkening coin-
cidence with growth hormone treatment. Her parents were
non-consanguineous, and no one else in the family had similar
pigmentation. Physical examination revealed a short stature
and the subtle facial features of Turner syndrome. Cutaneous
examination revealed a bilateral, diffuse, homogenous, slate-
colored, blue-gray patch over the forehead, periorbital area,
temples, nasal bridge and sclerae (Figs. 1 and 2). Nasal and
oral mucosae were not affected. Other Turner syndrome fea-
tures, including wide spaced nipples and wide carrying angle,
were also present.
Ophthalmologic examination revealed scleral and conjuncti-
val pigmentation, nystagmus and esotropia. Cardiologic and
audiometric examinations were normal. Renal and ovarian
ultrasounds were normal. Histopathologic study showed nor-
mal epidermis and the presence of numerous elongated, spin-
dle-shaped melanocytes with their long axis parallel to the
skin surface and scattered between the collagen bundles in
the mid-dermis (Figs. 3 and 4).
Based on clinical ﬁndings and the complementary examin-
ations performed, the diagnosis of Turner syndrome associated
Figure 2 Side view of the face showing diffuse slate – bluish-gray
patch forehead, periorbital area and temple (eyes closed).
Figure 3 AP view shows bilateral nevus of Ota with bilateral
scleral involvement.
Figure 4 Skin biopsy show normal epidermis, dermis shows
multiple spindle shaped melanophages lying with their long axis
parallel to the skin surface and scattered between the collagen
bundle in the mid-dermis, unremarkable subcutis (haematoxylin
and eosin \ 200).
Figure 5 Skin biopsy shows dermal multiple spindle shaped
melanophages lying with their long axis parallel to the skin surface
and scattered between the collagen bundle in the mid-dermis
(haematoxylin and eosin \ 400).
Figure 1 Side view of the face showing diffuse slate – bluish-gray
patch forehead, periorbital area and temple (eyes open).
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currently undergoing treatment with the Q-switched alexan-
drite laser with 755 nm wavelength, 3 mm spot size, and 7 J/
cm2 (see Fig. 5).2. Discussion
Nevus of Ota was ﬁrst described by a Japanese dermatologist,
Ota, who described an unusual syndrome of Nevus fusco-
caeruleus ophthalmo-maxillaris in 1939 (Ota, 1939a,b). It is
very common in Asians, especially in the Japanese population,
but is also seen in people of Chinese, Indians, African and
European descent. Several epidemiological studies have shown
higher prevalence in Japan with rates between 0.4% and 1.1%
(Yoshida, 1952; Tanino, 1939; Hidano et al., 1967). A Cana-
dian study in Black populations revealed an incidence of up
to 0.014% (Gonder et al., 1982). About 80% of the patients
were females (Kopf and Weidman, 1962). Forty-eight percent
of patients developed a nevus of Ota at or after birth compared
to 11% between 1 and 10 years of age and 36% at puberty
Table 1 Types of nevus of Ota.
Type I (A) Mild orbital type: distribution over the upper and lower eyelids, periocular and temple regions
(B) Mild zygomatic type: pigmentation is found in the infrapalpebral fold, nasolabial fold and the zygomatic region
(C) Mild forehead type: involvement of the forehead alone
(D) Involvement of ala nasi alone
Type II Moderate type: distribution over the upper and lower eyelids, periocular, zygomatic, cheek and temple regions
Type III The lesion involves the scalp, forehead, eyebrows and nose
Type IV Bilateral type: both sides are involved
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multifactorial, including genetic factors, as the lesion has a
much higher incidence among Asians than in other popula-
tions (Loche and Bazex, 1999). Other stimulus factors are fe-
male sex hormones, ultraviolet light exposure and trauma
(Kopf and Weidman, 1962). Histopathology of affected skin
shows the presence of a benign dendritic melanocytosis con-
taining melanin in the dermis (Kishikawa et al., 1997). The
clinical manifestations are usually unilateral, and only 5% of
cases are bilateral (De Las Heras et al., 1991). Presentation
is characterised by the presence of blue-gray macular pigmen-
tation with irregular borders and commonly involves skin and
mucosa innervated by the ophthalmic, maxillary and rarely
mandibular division of the trigeminal nerve (De Las Heras
et al., 1991). Tanino classiﬁed nevus of Ota into four types,
depending on the extent and distribution of pigmentation
(Tanino, 1939), and according to this classiﬁcation, this case
would correspond to type IV (see Table 1).
Apart from skin and scleral involvement, pigmentation has
been documented in the episclera, conjunctiva, cornea, iris, ret-
ina and uveal tract. Similar discoloration can be observed in
oral and nasal mucosae and the tympanic membrane. Lepto-
meninges can also be affected (Patel et al., 1998). Open-angle
glaucoma (Liu and Ball, 1991) and melanoma (Fulk and Mor-
ristown, 1984; Hartmann et al., 1981; Koca et al., 1992) are
rarely associated with nevus of Ota with only about 10 cases
of cutaneous melanoma in nevus of Ota documented to date.
Melanoma arising in the brain and optical structures are more
frequently associated with this type of lesion (Patel et al., 1998;
Theunissen et al., 1993).
Turner syndrome is a sex chromosome disorder with an
incidence between 1:2000 and 1:5000 live female births (Hook
and Warburton, 1983; Gibbs et al., 2001). The deﬁning clinical
triad of impaired sexual development and webbed neck was
ﬁrst described in the English-language literature by Turner
(1938), and later ovarian failure and streaked gonads were
noted by Wilkins and Fleischmann (1944). The main features
of this syndrome are short stature, impaired sexual develop-
ment, infertility, webbed neck and lymphedema. Turner syn-
drome has been associated with many coincident cutaneous
dermatoses. Although most patients with Turner syndrome
have an increased number of acquired melanocytic nevi
(Becker et al., 1994; Zvulunov et al., 1998), it is still unclear
if this predisposes these individuals to melanoma, as it does
in the rest of the population, or if Turner syndrome has some
protective effect againstmelanoma (Schoemaker and Swerdlow,
2008; Gibbs et al., 2001). Because many case reports of mela-
noma have been reported with nevus of Ota, the risk of mela-
noma in our case needs to be considered. Other cutaneous
associations with Turner syndrome are halo nevus (Oiso
et al., 2007), vitiligo (Lowenstein et al., 2004; Hatipoglu andKutoglus, 2000), neuroﬁbromatosis (Lee and Yoo, 1996), lym-
phoedema (Rosina and Segalla, 2003), alopecia areata (Rosina
and Segalla, 2003; Yang et al., 1996) and psoriasis (Yang et al.,
1996; Lowenstein et al., 2004).
Various therapies have been used to treat nevus of Ota suc-
cessfully. Cosmetic cover-up products can be used for camou-
ﬂage. Cryosurgery and microsurgical treatments can leave
disﬁguring scars and are not recommended. Combined derm-
abrasion and carbon dioxide lasers have yielded good results
(Shinichi and Hisahi, 1994). Treatment with photothermolysis
with Q-switched lasers is safe and effective for lightening nevi
of Ota (Omprakash, 2002; Chan et al., 2000; Kono et al.,
2001). Side effects such as mild purpura, erythema and edema
can follow the treatment and resolve after a few days,
but pigmentation changes, such as hyperpigmentation or
hypopigmentation, are more frequent. Topical tretinoin,
hydroquinone, and corticosteroid creams can be used in the
treatment of post-inﬂammatory hyperpigmentation (Ueda
et al., 2000; Lu et al., 2000). The response to laser treatment
has been reported to be dependent on lesion color. Darker le-
sions, which have a greater number of melanocytes, require
more treatments for eradication (Chan et al., 2000). Overall,
laser therapy is very effective in the treatment of nevus of
Ota, and recurrence is rare (Omprakash, 2002; Ueda et al.,
2000).
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